Cronos Pharma has announced a senior leadership appointment as part of its efforts to reinforce its management structure for the new year. The company stated that Tan Aknil has taken office as General Manager as of January 5, 2026.
With extensive executive experience in the pharmaceutical and healthcare sectors, Aknil has held senior roles across a range of national and international organizations throughout his career. In his new position, he will lead the implementation of Cronos Pharma’s growth strategies, support organizational development, and contribute to the creation of sustainable business models. The company also aims to improve operational efficiency while evaluating new business opportunities under this leadership.
Operating under Açık Holding’s investments in healthcare, Cronos Pharma focuses on the dietary supplements (OTC) segment, aligned with a preventive healthcare approach. The company positions itself around quality and reliability, supported by a strong R&D infrastructure and production carried out at its own facilities. Cronos Pharma stated that it continues to closely monitor industry developments and aims to continuously improve its products and processes.
Cronos Pharma also emphasized that it will continue its activities with a management approach centered on scientific principles and ethical values, while pursuing sustainable growth in the healthcare sector.
